Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online August 1, 2019.
Article Versions
- You are currently viewing a Latest version of this article (August 1, 2019 - 04:00).
- latest version (June 15, 2020 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2019 The Journal of Rheumatology
Author Information
- Mark C. Hwang,
- Alexis Ogdie,
- Abin Puravath and
- John D. Reveille
- Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, John P. and Kathrine G. McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, TX; Division of Rheumatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
This project was supported by the National Institute of Health PO1- AR052915. The project has not received financial support from any commercial interests. AO has served as a consultant for AbbVie, Amgen, BMS, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda and has received grants to the University of Pennsylvania from Pfizer and Novartis. JDR has served as a consultant for Janssen, Lilly, Novartis and Pfizer. AO is supported by K23 AR063764, R01 AR072363 and the Rheumatology Research Foundation. JDR is supported by the Spondyloarthritis Association of America.
Address correspondence to Mark C. Hwang, M.D. John P. and Kathrine G. McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, TX. – 6431 Fannin MSB.5276, Houston, TX 77030. Email: Mark.C.Hwang@uth.tmc.edu